Clinical Trials Logo

Smoking Cessation clinical trials

View clinical trials related to Smoking Cessation.

Filter by:

NCT ID: NCT01352195 Completed - Smoking Cessation Clinical Trials

Extended Self-Help for Smoking Cessation

Start date: January 23, 2009
Phase: N/A
Study type: Interventional

The primary purpose of this study is smoking cessation. The investigators are conducting a research study to learn how well the information from the program helps participants to quit smoking and remain smoke-free.

NCT ID: NCT01352000 Completed - Smoking Cessation Clinical Trials

Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline("Quitline")

Start date: December 2008
Phase: N/A
Study type: Interventional

The study primary purpose is smoking relapse prevention. This study is a collaboration between researchers who developed the relapse-prevention intervention, at the H. Lee Moffitt Cancer Center in Tampa, Florida, and those associated with the "New York State Smokers' Quitline" (NYSSQL), at Roswell Park Cancer Institute in Buffalo, New York.

NCT ID: NCT01342523 Completed - Smoking Cessation Clinical Trials

Evaluation of National Cancer Institute (NCI) Smoking Intervention Resources

NCI
Start date: October 2011
Phase: Phase 4
Study type: Interventional

This is an evaluative study of three National Cancer Institute (NCI) smoking cessation resources: specifically, the smokefree.gov and women smokefree.gov websites, and the CIS counseling phone calls. The following are the identified critical questions: (1). How effective is each of the tobacco interventions (websites [smokefree.gov & women smokefree.gov], NCI's Cessation Quitline counseling services operated by the Cancer Information Service (CIS) (2). How do they compare with alternative intervention strategies? (3). Which types of interventions appear to work best together (due to additive or interactive effects)? (4). How do these interventions work? (5). How much are these interventions used, and what are their relative use rates? (6). Are there important differences in effectiveness or use rates as a function of gender, SES, or other important person factors? We believe that the research study will address all of these questions, as well as some less central ones.

NCT ID: NCT01330043 Active, not recruiting - Smoking Cessation Clinical Trials

Extended Treatment for Smoking Cessation

Start date: March 2010
Phase: N/A
Study type: Interventional

Adult smokers (21-65) and adolescent smokers (18 - 21) years of age residing in Alameda and Santa Clara counties will serve as the target population for this study. A total of 400 smokers meeting eligibility criteria will be randomized. Treatment will include both open label and extended treatment phases. Randomization. Participants will be randomized to extended therapy or control conditions at baseline (prior to open label treatment) and the analysis will be intention-to-treat (ITT) to avoid the threat of selection bias. Primary hypothesis. Smokers randomized to receive CBT during extended treatment will have a higher prolonged abstinence rate (PA) at 52 week and 104 week follow-up than participants in the Supportive therapy Control treatment.

NCT ID: NCT01328431 Completed - Smoking Cessation Clinical Trials

Treating Low-Income Smokers in the Hospital Emergency Department

Start date: October 2010
Phase: N/A
Study type: Interventional

This study will test the effectiveness of an Emergency Department (ED) initiated tobacco intervention which includes counseling and medication. Our proposed intervention combines a Brief Negotiated Interview (BNI) with initiation of nicotine patch and gum in the ED, as well as a faxed referral to the state's Smokers' Quitline. A 6 week supply of nicotine patches and nicotine gum are provided to subjects in the intervention arm. Subjects randomized to the control arm will receive a brochure from the state's Smokers' Quitline only. The primary hypothesis is that the intervention will be superior to the control condition in reducing self-reported and biochemically verified 7-day tobacco abstinence at 3 months.

NCT ID: NCT01312909 Completed - Smoking Cessation Clinical Trials

Smoking Cessation Study In Healthy Adolescent Smokers

Start date: April 2011
Phase: Phase 4
Study type: Interventional

The study is designed to see if varenicline combined with age appropriate (adolescent) smoking cessation counseling will help teens quit smoking.

NCT ID: NCT01310842 Completed - Smoking Cessation Clinical Trials

Social Determinants and Smoking Cessation

Start date: July 2012
Phase: N/A
Study type: Observational

The goal of this study is to learn about the influence of the social and physical environment on smoking cessation (quitting smoking) among smokers.

NCT ID: NCT01309217 Completed - Smoking Cessation Clinical Trials

Dissemination of Tobacco Tactics for Hospitalized Smokers

Start date: July 2011
Phase: Phase 4
Study type: Interventional

Nurse-administered smoking cessation interventions have been shown to be efficacious, but are seldom implemented due to lack of training and time. This project aims to disseminate and test the nurse-administered Tobacco Tactics intervention in 6 hospitals.

NCT ID: NCT01304810 Completed - Smoking Cessation Clinical Trials

A Follow-up Study to Assess Long-term Immunogenicity and Safety of NicVAX/Placebo as an Aid to Smoking Cessation

Start date: January 2011
Phase: Phase 3
Study type: Observational

The purpose of the study is to obtain two year follow up data for subjects that received six vaccinations of NicVAX in prior phase III studies. No treatment will be administered. Anti-nicotine antibody levels and safety data will be collected.

NCT ID: NCT01299896 Completed - Smoking Cessation Clinical Trials

Connect to Quit for Smoking

CTQ
Start date: March 2011
Phase: N/A
Study type: Interventional

The purpose of this research study is to examine the effectiveness of an intervention designed to reduce smoking in low income veterans within a regional United States Veterans Administration(VA) health care system. A proactive, personalized, coordinated system of care "Connect to Quit (CTQ)" is rooted in the Chronic Care Model. CTQ treats smoking as a chronic condition, like hypertension or diabetes, that requires long term treatment with appropriate combinations of behavioral therapy and pharmacotherapy. CTQ will be evaluated in the context of three (3) VA Pittsburgh Healthcare System (VAPHS) medical practices.